Toxicity of Cancer Therapy: What the Cardiologist Needs to Know about Angiogenesis Inhibitors

Clinical outcomes for patients with a wide range of malignancies have improved substantially over the last two decades. Tyrosine kinase inhibitors (TKI) are potent signalling cascade inhibitors and have been responsible for significant advances in cancer therapy. By inhibiting vascular endothelial g...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Heart
Asıl Yazarlar: Dobbin, Stephen JH, Cameron, Alan C, Petrie, Mark C, Jones, Robert J, Touyz, Rhian M, Lang, Ninian N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6268130/
https://ncbi.nlm.nih.gov/pubmed/30228246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2018-313726
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller